Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles in Liver Injury

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Nov 27

PMID 39595055

Authors

Jingjing Dong

Ying Luo

Yingtang Gao

Affiliations

Soon will be listed here.

Abstract

Liver injury caused by various factors significantly impacts human health. Stem cell transplantation has potential for enhancing liver functionality, but safety concerns such as immune rejection, tumorigenesis, and the formation of emboli in the lungs remain. Recent studies have shown that stem cells primarily exert their effects through the secretion of extracellular vesicles (EVs). EVs have been shown to play crucial roles in reducing inflammation, preventing cell death, and promoting liver cell proliferation. Additionally, they can function as carriers to deliver targeted drugs to the liver, thereby exerting specific physiological effects. EVs possess several advantages, including structural stability, low immunogenicity, minimal tumorigenicity targeting capabilities, and convenient collection. Consequently, EVs have garnered significant attention from researchers and are expected to become alternative therapeutic agents to stem cell therapy. This article provides a comprehensive review of the current research progress in the use of stem cell-derived EVs in the treatment of liver injury.

References

Zhang Q, Piao C, Xu J, Wang Y, Liu T, Ma H . ADSCs-exo attenuates hepatic ischemia-reperfusion injury after hepatectomy by inhibiting endoplasmic reticulum stress and inflammation. J Cell Physiol. 2023; 238(3):659-669. DOI: 10.1002/jcp.30968. View

Tkach M, Thery C . Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell. 2016; 164(6):1226-1232. DOI: 10.1016/j.cell.2016.01.043. View

Lou G, Chen Z, Zheng M, Liu Y . Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017; 49(6):e346. PMC: 5519012. DOI: 10.1038/emm.2017.63. View

Rigo F, De Stefano N, Navarro-Tableros V, David E, Rizza G, Catalano G . Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model. Transplantation. 2018; 102(5):e205-e210. DOI: 10.1097/TP.0000000000002123. View

Yao J, Zheng J, Cai J, Zeng K, Zhou C, Zhang J . Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2018; 33(2):1695-1710. DOI: 10.1096/fj.201800131RR. View

Cheng Y, Chen K, Sung Y, Yang C, Chien C . Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis. Antioxidants (Basel). 2022; 11(9). PMC: 9495781. DOI: 10.3390/antiox11091702. View

Bi J, Zhang J, Ren Y, Du Z, Li Q, Wang Y . Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 2018; 20:296-306. PMC: 6216086. DOI: 10.1016/j.redox.2018.10.019. View

Sharma M, Pondugala P, Jaggaihgari S, Mitnala S, Krishna V, Jaishetwar G . Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study. J Clin Exp Hepatol. 2022; 12(1):80-88. PMC: 8766547. DOI: 10.1016/j.jceh.2021.03.010. View

Wang Q, Liu Z, Wang J, Wang H, Li A, Yang Y . Glutathione peroxidase-1 is required for self-renewal of murine embryonic stem cells. Biochem Biophys Res Commun. 2014; 448(4):454-60. DOI: 10.1016/j.bbrc.2014.04.139. View

10.

Saat T, van den Engel S, Bijman-Lachger W, Korevaar S, Hoogduijn M, IJzermans J . Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection. Stem Cells Int. 2016; 2016:5761487. PMC: 4766354. DOI: 10.1155/2016/5761487. View

11.

Camussi G, Deregibus M, Cantaluppi V . Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013; 41(1):283-7. DOI: 10.1042/BST20120192. View

12.

Gong Y, Dai H, Liu W, Liao R, Chen H, Zhang L . Exosomes derived from human adipose-derived stem cells alleviate hepatic ischemia-reperfusion (I/R) injury through the miR-183/ALOX5 axis. FASEB J. 2023; 37(3):e22782. DOI: 10.1096/fj.202200277R. View

13.

Feng Y, Li Y, Xu M, Meng H, Dai C, Yao Z . Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis. Stem Cell Res Ther. 2022; 13(1):375. PMC: 9331515. DOI: 10.1186/s13287-022-03069-7. View

14.

Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J . Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury. J Cell Physiol. 2017; 233(12):9330-9344. DOI: 10.1002/jcp.26413. View

15.

Zheng J, Lu T, Zhou C, Cai J, Zhang X, Liang J . Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Liver Ischemia/Reperfusion Injury by Reducing CD154 Expression on CD4+ T Cells via CCT2. Adv Sci (Weinh). 2020; 7(18):1903746. PMC: 7509664. DOI: 10.1002/advs.201903746. View

16.

Yang B, Duan W, Wei L, Zhao Y, Han Z, Wang J . Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cell Exosomes Reduce Hepatic Ischemia/Reperfusion Injury by Enhancing Autophagy. Stem Cells Dev. 2020; 29(6):372-379. DOI: 10.1089/scd.2019.0194. View

17.

Zhao S, Huang M, Yan L, Zhang H, Shi C, Liu J . Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway. Oxid Med Cell Longev. 2022; 2022:8287227. PMC: 9334037. DOI: 10.1155/2022/8287227. View

18.

Wei X, Zheng W, Tian P, Liu H, He Y, Peng M . Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell-derived exosome against acute liver ischemia-reperfusion injury. J Cell Mol Med. 2020; 24(19):11211-11220. PMC: 7576231. DOI: 10.1111/jcmm.15675. View

19.

Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H . 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. J Nanobiotechnology. 2021; 19(1):437. PMC: 8686281. DOI: 10.1186/s12951-021-01138-2. View

20.

Li J, Li R, Lv G, Liu H . The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci. 2015; 19(11):2036-47. View